Holly A. Swartz, MD

Dr Swartz is a professor of psychiatry and the director of the Center for Advanced Psychotherapy at the University of Pittsburgh School of Medicine.

Articles by Holly A. Swartz, MD

Beyond Deprescribing: A Formula for Excellent Clinical Care

ByJoseph F. Goldberg, MD,Anita H. Clayton, MD,Leslie L. Citrome, MD, MPH,David W. Goodman, MD,Rajnish Mago, MD,Roger S. McIntyre, MD, FRCPC,Holly A. Swartz, MD,Mauricio Tohen, MD,John J. Miller, MD,Psychiatric Times Editors

July 13th 2026

A panel of expert psychiatrists define deprescribing as ongoing medication review, guiding safer, personalized psychopharmacology amid polypharmacy, misdiagnosis, and fragmented care.

Podcast: Deprescribing Insights From an ASCP Panel of Psychiatric Experts

ByJoseph F. Goldberg, MD,Roger S. McIntyre, MD, FRCPC,Rajnish Mago, MD,Anita H. Clayton, MD,Holly A. Swartz, MD,David W. Goodman, MD ,Leslie L. Citrome, MD, MPH,Mauricio Tohen, MD

July 3rd 2026

ASCP panel offers deprescribing guidance to curb psychiatric overprescribing, simplify polypharmacy, and improve outcomes with tapering and

Brain Trust: The First Panel of Psychiatric Experts Weighs in on Deprescribing at ASCP 2026

ByJoseph F. Goldberg, MD,Roger S. McIntyre, MD, FRCPC,Rajnish Mago, MD,Anita H. Clayton, MD,Holly A. Swartz, MD,David W. Goodman, MD ,Leslie L. Citrome, MD, MPH,Mauricio Tohen, MD

May 28th 2026

Expert psychiatrists share new ASCP deprescribing guidance, tackling overprescribing, primary-care challenges, and practical tapering strategies to improve safer, patient-centered mental health care.

Podcast: The Intersection of Psychotherapy and Psychopharmacology for Mood Disorders. Optimizing Patient Outcomes With Holly A. Swartz, MD

ByJoseph F. Goldberg, MD,Holly A. Swartz, MD

May 1st 2026

Learn when CBT/IPT beats medications, when to combine antidepressants, and why patient preference drives depression recovery in 6–12 weeks in this podcast.

Brain Trust: Evidence-Based Treatment for Mood Disorders, A Conversation With Holly A. Swartz, MD

ByJoseph F. Goldberg, MD,Holly A. Swartz, MD

October 17th 2025

Explore the intersection of psychotherapy and pharmacology in treating mood disorders, emphasizing personalized approaches for optimal patient outcomes.

Holly A. Swartz, MD

Articles by Holly A. Swartz, MD

Beyond Deprescribing: A Formula for Excellent Clinical Care

Podcast: Deprescribing Insights From an ASCP Panel of Psychiatric Experts

Brain Trust: The First Panel of Psychiatric Experts Weighs in on Deprescribing at ASCP 2026

Podcast: The Intersection of Psychotherapy and Psychopharmacology for Mood Disorders. Optimizing Patient Outcomes With Holly A. Swartz, MD

Brain Trust: Evidence-Based Treatment for Mood Disorders, A Conversation With Holly A. Swartz, MD

Latest Updated Articles

Trending on Psychiatric Times

FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults

Quiet Comfort: New Details on COMP360 Psilocybin Administration Sessions for the Treatment of PTSD

Attachment-Based Therapy in Adolescent Substance Users: A Meta-Synthesis of Emotional Isolation and Avoidant Attachment Patterns

What Designing AI Taught Me About Why Psychiatrists Ignore It

Preventing Alzheimer Disease After Brain Injury: Targeting TNF With XPro1595